| ALK | Anaplastic lymphoma kinase |
| ATX | Autotaxin |
| BC | Breast cancer |
| BM | Basement membrane |
| BMP | Bone morphogenic protein |
| CAF | Cancer-associated fibroblast |
| CAR | Chimeric antigen receptor |
| CA15-3 | Cancer antigen 15-3 |
| CD44 | Cluster of differentiation 44 |
| CDKN1A | Cyclin-dependent kinase inhibitor 1A |
| CEA | Carcinoembryonic antigen |
| COL | Collagen |
| CS | Chondroitin sulfate |
| CSPG4/NG2 | Chondroitin sulfate proteoglycan 4/neural/glial antigen 2 |
| DS | Dermatan sulfate |
| ECM | Extracellular matrix |
| EGFR | Epithelial growth factor receptor |
| EMT | Epithelial–mesenchymal transition |
| EPCR | Endothelial protein C receptor |
| ER | Estrogen receptor |
| FAP | Fibroblast activation protein alpha |
| FGF | Fibroblast growth factor |
| FGF2 | Fibroblast growth factor 2 |
| GAG | Glycosaminoglycan |
| GPC | Glypican |
| GPI | Glycosylphosphatidylinositol |
| HA | Hyaluronic acid |
| Hep | Heparin |
| HER2 | Human epidermal growth factor receptor 2 |
| Hh | Hedgehog |
| HIF | Hypoxia-inducible factor |
| HS | Heparan sulfate |
| HSPG | Heparan sulfate proteoglycan |
| IGFR | Insulin-like growth factor receptor |
| IL | Interleukin |
| KS | Keratan sulfate |
| MMP | Matrix metalloproteinase |
| NCAM | Neural cell adhesion molecule |
| NFAT | Nuclear factor of activated T-cells |
| PCM | Pericellular matrix |
| PDGF | Platelet-derived growth factor |
| PG | Proteoglycan |
| PRELP | Leucine-rich repeat protein |
| PTM | Post-translational modification |
| PTN | Pleiotrophin |
| RTK | Receptor tyrosine kinase |
| SLRP | Small leucine-rich proteoglycan |
| SPARC | Secreted protein acidic and rich in cysteine |
| SPOCK | Secreted protein acidic and rich in cysteine/Osteonectin CWCV and Kazal-like domain proteoglycan |
| TAM | Tumour-associated macrophage |
| TF | Tissue factor |
| TFPI | Tissue factor pathway inhibitor |
| TGF | Transforming growth factor |
| TIL | Tumour-infiltrating lymphocyte |
| TLR | Toll-like receptor |
| TME | Tumour microenvironment |
| TNBC | Triple-negative breast cancer |
| TNF | Tumour necrosis factor |
| TSP-1 | Thrombospondin-1 |
| VEGF | Vascular endothelial growth factor |
| VCAN | Versican |
| VM | Vasculogenic mimicry |
| Wnt | Wingless/Integrated signaling pathway |